Clinical Trial Update: Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease ; ( LiPo-A )

View source ↗

Summary

A case-series update describes using double-filtration plasmapheresis to lower Lipoprotein(a) in hemodialysis patients with chronic kidney disease. The LiPo-A s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: Centre Hospitalier Régional Metz-Thionville | Conditions: Lipoprotein(a), Lipoprotein-apheresis | Status: COMPLETED